Abstract
This Article argues that the nearly unanimous opinion in the medical research and public policy communities that tissue donors should be subject to a no-compensation rule is misguided and that purchasing tissues for biomedical research should be both legal and socially acceptable. For readers who remain unconvinced, it then describes less restrictive alternatives to pure no-compensation rules as "second-best" solutions. It concludes by observing the distinct differences between markets for research tissues and markets for transplant tissues.
How to Cite
49 Ariz. L. Rev. 45 (2007)
28
Views
32
Downloads